Catalyst Pharmaceuticals, Inc. (CPRX)
31.23
+0.05
(+0.16%)
USD |
NASDAQ |
May 18, 13:16
Catalyst Pharmaceuticals Research and Development Expense (Quarterly) : 2.661M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 2.597M |
| Inovio Pharmaceuticals, Inc. | 13.75M |
| United Therapeutics Corp. | 138.20M |
| Regeneron Pharmaceuticals, Inc. | 1.420B |
| Agios Pharmaceuticals, Inc. | 79.78M |